IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic

Paulo H. Verardi, Fatema A. Legrand, Kenneth S. Chan, Yue Peng, Leslie A. Jones, Tilahun Yilma

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Interferon-γ (IFN-γ) is an attenuating factor for vaccinia virus (VACV), decreasing its virulence in vivo by more than a million fold. It is also a highly effective adjuvant when administered at the time of immunization with protein antigens. However, recombinant VACV (rVACV) vaccines expressing IFN-γ do not induce enhanced immune responses. It is possible that the IFN-γ expressed by rVACVs induces both an antiviral state and increased immunological clearance, thus resulting in decreased levels of antigen expression due to reduced viral replication and spread. We conjectured that delaying expression of IFN-γ would result in enhanced production of antigens by rVACVs thus resulting in increased immune responses to foreign antigens. Interleukin (IL)-18, also known as IFN-γ inducing factor, is a cytokine that induces T and NK cells to produce IFN-γ. In this study, we demonstrated that an rVACV expressing bioactive murine IL-18 replicated to low but detectable levels in vivo, unlike an rVACV expressing IFN-γ. Moreover, the rVACV expressing IL-18 was significantly attenuated in both immunocompromised and immunocompetent mice. This attenuation was dependent on IFN-γ, as IL-18 expression failed to attenuate VACV in IFN-γ knock-out mice. Cytotoxic T-cell (CTL) and anamnestic antibody responses were slightly increased in animals vaccinated with the rVACV expressing IL-18. Thus, induction of IFN-γ because of IL-18 expression resulted in an rVACV that replicated to low but detectable levels in vivo, yet elicited slightly better CTL and anamnestic humoral immune responses.

Original languageEnglish (US)
Pages (from-to)169-178
Number of pages10
JournalJournal of Interferon and Cytokine Research
Volume34
Issue number3
DOIs
StatePublished - Mar 1 2014

Fingerprint

Interleukin-18
Vaccinia virus
Interferons
Antigens
T-Lymphocytes
Humoral Immunity
Knockout Mice
Natural Killer Cells
Antibody Formation
Antiviral Agents
Virulence
Immunization
Vaccines
Cytokines

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Cell Biology

Cite this

IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic. / Verardi, Paulo H.; Legrand, Fatema A.; Chan, Kenneth S.; Peng, Yue; Jones, Leslie A.; Yilma, Tilahun.

In: Journal of Interferon and Cytokine Research, Vol. 34, No. 3, 01.03.2014, p. 169-178.

Research output: Contribution to journalArticle

Verardi, Paulo H. ; Legrand, Fatema A. ; Chan, Kenneth S. ; Peng, Yue ; Jones, Leslie A. ; Yilma, Tilahun. / IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic. In: Journal of Interferon and Cytokine Research. 2014 ; Vol. 34, No. 3. pp. 169-178.
@article{2feb25ba12ec4f9389380be2efce7d38,
title = "IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic",
abstract = "Interferon-γ (IFN-γ) is an attenuating factor for vaccinia virus (VACV), decreasing its virulence in vivo by more than a million fold. It is also a highly effective adjuvant when administered at the time of immunization with protein antigens. However, recombinant VACV (rVACV) vaccines expressing IFN-γ do not induce enhanced immune responses. It is possible that the IFN-γ expressed by rVACVs induces both an antiviral state and increased immunological clearance, thus resulting in decreased levels of antigen expression due to reduced viral replication and spread. We conjectured that delaying expression of IFN-γ would result in enhanced production of antigens by rVACVs thus resulting in increased immune responses to foreign antigens. Interleukin (IL)-18, also known as IFN-γ inducing factor, is a cytokine that induces T and NK cells to produce IFN-γ. In this study, we demonstrated that an rVACV expressing bioactive murine IL-18 replicated to low but detectable levels in vivo, unlike an rVACV expressing IFN-γ. Moreover, the rVACV expressing IL-18 was significantly attenuated in both immunocompromised and immunocompetent mice. This attenuation was dependent on IFN-γ, as IL-18 expression failed to attenuate VACV in IFN-γ knock-out mice. Cytotoxic T-cell (CTL) and anamnestic antibody responses were slightly increased in animals vaccinated with the rVACV expressing IL-18. Thus, induction of IFN-γ because of IL-18 expression resulted in an rVACV that replicated to low but detectable levels in vivo, yet elicited slightly better CTL and anamnestic humoral immune responses.",
author = "Verardi, {Paulo H.} and Legrand, {Fatema A.} and Chan, {Kenneth S.} and Yue Peng and Jones, {Leslie A.} and Tilahun Yilma",
year = "2014",
month = "3",
day = "1",
doi = "10.1089/jir.2013.0052",
language = "English (US)",
volume = "34",
pages = "169--178",
journal = "Journal of Interferon and Cytokine Research",
issn = "1079-9907",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic

AU - Verardi, Paulo H.

AU - Legrand, Fatema A.

AU - Chan, Kenneth S.

AU - Peng, Yue

AU - Jones, Leslie A.

AU - Yilma, Tilahun

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Interferon-γ (IFN-γ) is an attenuating factor for vaccinia virus (VACV), decreasing its virulence in vivo by more than a million fold. It is also a highly effective adjuvant when administered at the time of immunization with protein antigens. However, recombinant VACV (rVACV) vaccines expressing IFN-γ do not induce enhanced immune responses. It is possible that the IFN-γ expressed by rVACVs induces both an antiviral state and increased immunological clearance, thus resulting in decreased levels of antigen expression due to reduced viral replication and spread. We conjectured that delaying expression of IFN-γ would result in enhanced production of antigens by rVACVs thus resulting in increased immune responses to foreign antigens. Interleukin (IL)-18, also known as IFN-γ inducing factor, is a cytokine that induces T and NK cells to produce IFN-γ. In this study, we demonstrated that an rVACV expressing bioactive murine IL-18 replicated to low but detectable levels in vivo, unlike an rVACV expressing IFN-γ. Moreover, the rVACV expressing IL-18 was significantly attenuated in both immunocompromised and immunocompetent mice. This attenuation was dependent on IFN-γ, as IL-18 expression failed to attenuate VACV in IFN-γ knock-out mice. Cytotoxic T-cell (CTL) and anamnestic antibody responses were slightly increased in animals vaccinated with the rVACV expressing IL-18. Thus, induction of IFN-γ because of IL-18 expression resulted in an rVACV that replicated to low but detectable levels in vivo, yet elicited slightly better CTL and anamnestic humoral immune responses.

AB - Interferon-γ (IFN-γ) is an attenuating factor for vaccinia virus (VACV), decreasing its virulence in vivo by more than a million fold. It is also a highly effective adjuvant when administered at the time of immunization with protein antigens. However, recombinant VACV (rVACV) vaccines expressing IFN-γ do not induce enhanced immune responses. It is possible that the IFN-γ expressed by rVACVs induces both an antiviral state and increased immunological clearance, thus resulting in decreased levels of antigen expression due to reduced viral replication and spread. We conjectured that delaying expression of IFN-γ would result in enhanced production of antigens by rVACVs thus resulting in increased immune responses to foreign antigens. Interleukin (IL)-18, also known as IFN-γ inducing factor, is a cytokine that induces T and NK cells to produce IFN-γ. In this study, we demonstrated that an rVACV expressing bioactive murine IL-18 replicated to low but detectable levels in vivo, unlike an rVACV expressing IFN-γ. Moreover, the rVACV expressing IL-18 was significantly attenuated in both immunocompromised and immunocompetent mice. This attenuation was dependent on IFN-γ, as IL-18 expression failed to attenuate VACV in IFN-γ knock-out mice. Cytotoxic T-cell (CTL) and anamnestic antibody responses were slightly increased in animals vaccinated with the rVACV expressing IL-18. Thus, induction of IFN-γ because of IL-18 expression resulted in an rVACV that replicated to low but detectable levels in vivo, yet elicited slightly better CTL and anamnestic humoral immune responses.

UR - http://www.scopus.com/inward/record.url?scp=84895887747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895887747&partnerID=8YFLogxK

U2 - 10.1089/jir.2013.0052

DO - 10.1089/jir.2013.0052

M3 - Article

C2 - 24168450

AN - SCOPUS:84895887747

VL - 34

SP - 169

EP - 178

JO - Journal of Interferon and Cytokine Research

JF - Journal of Interferon and Cytokine Research

SN - 1079-9907

IS - 3

ER -